Skip to main content
. 2016 Aug 6;7(1):73–79. doi: 10.1016/j.apsb.2016.05.003

Figure 1.

Fig. 1

(A) Structures of some biologically active molecules with diaryl pharmacophore and different heterocyclic scaffolds employed for stabilizing the ‘cis’ diaryl configuration in literature; (B) Structures of molecules 2,3-diaryl-3H-imidazo[4,5-b]pyridine derivatives evaluated in this study.